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Abstract
Background: Obstetric hemorrhage (OH) remains one of the leading causes of maternal mortality, particularly in
rural Africa. Tanzania has a high maternal mortality ratio, and approximately 80% of the population accesses health
care lower level facilities, unable to provide Comprehensive Emergency Obstetric Care (CEmOC). The non-pneumatic
anti-shock garment (NASG) has been demonstrated to reduce mortality as it buys time for women in shock to be
transported to or to overcome delays at referral facilities.
Methods: This report describes one component of an ongoing maternal health improvement project, Empower,
implemented in 280 facilities in four regions in rural Tanzania. The NASG along with a Closed User Group (CUG)
mobile phone network were implemented within the overall EmOC project. Simulation trainings, repeated trainings,
and close hands-on supportive supervision via site visits and via the CUG network were the training/learning methods.
Data collection was conducted via the CUG network, with a limited data collection form, which also included free text
options for project improvement. One-to-one interviews were also conducted. Outcome Indicators included
appropriate use of NASG for women with hypovolemic shock We also compared baseline case fatality rates
(CFR) from OH with endline CFRs.
Data were analyzed using cohort study Risk Ratio (RR). Qualitative data analysis was conducted by content analysis.
Results: Of the 1713 women with OH, 419 (24.5%) met project hypovolemic shock criteria, the NASG was applied to
70.8% (n = 297), indicating high acceptability and utilization. CFR at baseline (1.70) compared to CFR at endline (0.76)
showed a temporal association of a 67% reduced risk for women during the project period (RR: 0.33, 95% CI
= .19, .60). Qualitative feedback was used to make course corrections during the project to enhance training and
implementation.
Conclusions: This implementation project with 280 facilities and over 1000 providers supported via CUG demonstrated
that NASG can have high uptake and appropriate use for hypovolemic shock secondary to OH. With the
proper implementation strategies, NASG utilization can be high and should be associated with decreased
mortality among mothers at risk of death from obstetric hemorrhage.
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Plain English summary
Obstetric hemorrhage (OH), defined as excessive bleeding
during pregnancy, childbirth, or the first 24 h after child-
birth, remains a leading cause of death for women, par-
ticularly in rural Africa. OH can lead to shock, a state in
which the body’s vital organs lack enough oxygen, which
leads to organ failure and death. In Tanzania women die
from bleeding and shock due to long distances from emer-
gency health services, Comprehensive Emergency Obstet-
ric Care (CEmOC). One way this problem has been
addressed is with the use of a lightweight, cost-efficient
compression garment, the non-pneumatic anti-shock gar-
ment (NASG), which stabilizes women who have lost ex-
cessive blood, allowing them to survive delays in travelling
to or receiving care at CEmOC facilities. Until now, there
have been questions if NASGs can be implemented effect-
ively in rural areas.
This study introduced the NASG at 280 health facil-
ities in rural Tanzania along with a Closed User Group
(CUG) mobile phone network. A CUG network is a ser-
vice from a cellular phone company which allows phone
calls to be made at no charge to other phones on the
same network.
Data was collected on 1713 women with OH, and
24.5% (419) of these women had signs of shock. The
NASG was applied to ~ 71%% (n = 297) of women with
shock, showing high uptake and appropriate use. The
rate of women dying from OH during the study at facil-
ities, called the case fatality rate (CFR), was reduced
during the study period.
Background
Obstetric hemorrhage (OH) is one of the leading causes
of maternal deaths, accounting for 33.9% of maternal
deaths in Africa to 13.4% of maternal deaths in devel-
oped countries, with the majority of deaths occurring in
low resource settings (LRCs) [1, 2]. Deaths due to
hemorrhage are highly preventable if managed appropri-
ately, but deaths frequently occur in rural areas far from
comprehensive emergency obstetric care (CEmOC) cen-
ters able to provide surgery and blood transfusions, the
definitive treatments for severe hemorrhage with hypo-
volemic shock [3, 4]. One first aid management tool for
hypovolemic shock secondary to obstetric hemorrhage is
the non-pneumatic anti-shock garment (NASG). This
low-technology, easy to apply, circumferential pressure
device, is made of stretchy compression neoprene and
closes tightly with Velcro, reversing shock, restoring vital
signs, and decreasing blood loss in the pelvis and uterus
[5]. This first aid device buys valuable time, to enable
transfer from rural and lower level facilities, and during
the often-long delays for blood transfusions or surgeries
that can occur, even in tertiary and university teaching
hospitals in LRCs.
Morbidity and mortality outcomes using the NASG
have been positively compared to outcomes with stand-
ard treatment of shock/hemorrhage in women with a
variety of OH etiologies, and the NASG was found to be
effective in decreasing blood loss by over 50% [6–9]. A
systematic review including 5 studies and 1247 women
[10] with OH /shock found a decreased mortality of 48%
(Relative Risk (RR) 0.52 (95% Confidence interval (CI)
0.36 to 0.77) at referral, tertiary-level facilities. A Cluster
Randomized Clinical Trial (CRCT) was conducted in
Zimbabwe and Zambia [9] to determine if early applica-
tion of the NASG at the primary health facility level im-
proved outcomes compared to later application at the
referral facilities. The reduction in mortality was clinic-
ally significant at 55%, but there was an inadequate sam-
ple of women in hypovolemic shock (actual sample size,
n = 880 vs. the predicted n = 2400) necessary to have
adequate power to determine statistical significance [11].
The NASG is currently recommended by the Inter-
national Federation of Gynecologists and Obstetricians
(FIGO) [12] and the World Health Organization (WHO)
[13] and can be found in PPH guidelines and manuals,
such as WHO (Managing Complications 2nd edition)
[14], Global Library of Women’s Medicine (GLOWM)
PPH Recommendations [15], and JHPIEGO’s Helping
Mothers Survive Bleeding After Birth [16], as well as in
JHPIEGO’s 2018, 5-year report “Survive and Thrive”
[17]. A healthcare technology assessment performed for
WHO [18] resulted in a positive recommendation for in-
cluding the NASG in Emergency Maternal and Obstetric
Care (EMOC) management. In 2015 the UN Commis-
sion on Life-Saving Commodities for Women and Chil-
dren (UNCoLSC), the Clinton Health Access Initiative,
Inc. (CHAI), the Safe Motherhood Program at the Uni-
versity of California, San Francisco (UCSF), and the Blue
Fuzion Group entered into an agreement to decrease
costs of the NASG by 75% in order to enhance NASG
scale up in LMICs [19].
Despite these global recommendations and endorsements
and despite pilot implementation and scale up projects con-
ducted in India [20, 21], Nigeria [22], Ethiopia [23, 24],
Niger [25], Timor Leste [26], and Colombia [27], there have
been fewer publications on how the NASG is accepted and
used by clinicians and health systems [26, 28–31].
The publications/reports that have measured utilization
reported a range from 14% to 47% in Nigeria and Timor
Leste [26, 28, 30]. While not published, a few presenta-
tions on a two-phase evaluation of a national PPH
project in Niger, which introduced misoprostol, uter-
ine balloon tamponade (UBT), and NASG as a PPH
prevention and treatment package, reported extremely
low rates of use and raised the issue of a need for stra-
tegic planning around the use of the new technologies,
NASG (and UBT) [32–34].
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This paper will focus on utilization rates, provider ac-
ceptability, barriers to utilization, and those elements of
training and supportive supervision in-person and via
use of a Closed User Group (CUG) phone system,
which fostered higher, appropriate rates of NASG use
in a large maternal health implementation project in
rural Tanzania.
Methods
The 2010 Demographic and Health Survey revealed that
in 5 years, Tanzania reduced maternal mortality from
578 to 454 maternal deaths per 100,000 live births [35,
36]. While emergency obstetric care (EmOC) is available
at regional hospitals, a recent study of 22,243 live births
in rural districts of Tanzania found that only 29% of de-
liveries occurred in a hospital [3].
This project was a component of the Empower II Pro-
ject conducted by the Ifakara Health Institute (IHI),
which implements Maternal, Newborn and Child Health
(MNCH) interventions in real world settings to produce
learning for improvements and scale up. Empower I
lasted from July 2007 to June 2012 and Empower II
launched in March 2013. Collectively, Empower works
in four rural regions of Tanzania and targets a total
population of 3,919,342 of which 813,092 are women of
reproductive age. The NASG/CUG component described
below was conducted from November 2014 to June 2016.
Members of the University of California, San Francisco
(UCSF) Safe Motherhood Program served as consultants
for the NASG portion of the project.
This project component addressed challenges around
prompt management of OH and around OH referral be-
tween facilities through the introduction of the NASG
(LifeWrap-NASG, Hong Kong) along with a Closed User
Group (CUG) mobile phone network for public dispens-
aries, health centers, and three public referral hospitals,
as well as three private referral hospitals in the eight dis-
tricts of Geita, Nyang’hwale, Kalambo, Sumbawanga,
Singida, Ikungi, Shinyanga, and Kahama (Fig. 1 for a
map of the regions). A total of 280 facilities were en-
rolled: 17 Comprehensive Emergency Obstetric Care
(CEmOC) facilities and 263 Basic Emergency Obstetric
Care (BEmOC) facilities (17 health centers and 246 dis-
pensaries). To qualify as a CEmOC referral facility, a site
needed to have an operating theater and the capacity to
perform a blood transfusion. BEmOC level health cen-
ters served a population of 50,000 people and provide
inpatient care. Dispensaries provided the lowest level of
care, serving a population of 10,000 people, and offering
delivery beds and outpatient services. While dispensaries
were intended to provide BEmOC care, not every dis-
pensary was completely able to do so (the majority were
Fig. 1 Intervention regions. Study conducted in 2 districts in each of the 4 regions
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not able to perform these signal functions: parenteral an-
ticonvulsants, removal of retained product, and assisted
instrumental delivery).
In addition to the NASG, the project introduced mo-
bile phones on a CUG network. Five hundred eight cell
phones were supplied, three per CEmOC facility, 2 per
BEmOC facility, and four for each of the 8 Council
Health Management Teams (CHMT) with phone ser-
vice from the Airtel telecommunications company.
Phones on a CUG network may call other phones
within the network without airtime fees, so that health
workers could communicate about patients, call for an
ambulance, and contact IHI project staff for informa-
tion and support.
The study trained participants to use the NASG for
pregnant and postpartum women with hypovolemic
shock secondary to obstetric hemorrhage of any etiology:
ectopic pregnancy, molar pregnancy, complications of
abortion, retained placenta, placenta previa, uterine
atony, uterine rupture, and genital trauma. Women were
classified as having hypovolemic shock if they had any
amount of bleeding combined with either a systolic
blood pressure of ≤80 mmHg or altered consciousness.
Women were included whether the hemorrhage began
at home, at the facility, or at another site.
Training
Three phases of training were conducted: a Training of
Trainers (TOT) in October 2014, a series of Phase 1 train-
ings for CEmOC facilities was conducted in November
2014, and a series of Phase 2 training for BEmOC facilities
was conducted in February 2015. Sessions specific to the
NASG were 1.5–2 days in length and taught a curriculum
developed by the UCSF Safe Motherhood Program [cur-
riculum and training videos in English and a video of
training in Swahili are available at: http://www.safe-
motherhood.ucsf.edu/resources/videos/, the NASG/CUG
content was incorporated into scheduled Empower Emer-
gency Obstetric Care (EmOC) trainings.
At the TOT 19 trainers were certified to support on-
going cascade trainings as well as project supervision.
Only trainers who were able to pass a skills test and had
a written exam score of > 70% were certified to train for
the project. Phase 1 consisted of four trainings, one per
region at CEmOC facilities. Each facility sent four to five
CEmOC providers, who were trained in clinical manage-
ment of women with hypovolemic shock with the NASG
and how to train other facility staff in NASG use. A
phased approach was used, beginning project implemen-
tation only at district hospitals and other CEmOC health
facilities for the first 3 months of the program (Decem-
ber 2014 – February 2015), before moving to Phase 2
training and introduction of NASGs to lower level facil-
ities that referred patients to these CEmOC facilities.
Phase 2 consisted of 16 trainings in Swahili for BEmOC
health center and dispensaries, four trainings per re-
gion. The trainings were conducted in March–April
2015, BEmOC facilities sent two staff members to rep-
resent each dispensary and 3–4 staff for each health
center. These trainings were integrated with another
scheduled Empower training on maternal health service
provision. A total of 863 staff were trained in Phase 1
and Phase 2 by IHI, UCSF, and TOT trainers, including
surgeons, obstetricians, medical officers, midwives,
clinical assistants, registered nurses, clinical officers,
medical attendants, anesthetists, anesthesiologists, and
enrolled nurses.
At the start of Phase 2 meetings were held with IHI
project staff, district medical officers, and hospital ad-
ministrators to review the logistics for implementation,
as well as to hear their experiences and challenges dur-
ing the initial 3 months.
In December 2015, 20 ambulances were equipped with
NASGs (one per ambulance) and 21 drivers received
training on applying and transporting women with
NASGs. As an additional training tool for all levels of fa-
cilities, four-minute low resolution (7 MB) and high
resolution (11 MB) videos that instructed on NASG ap-
plication for average, short, large, and unconscious pa-
tients were uploaded to the CUG phones during
supervision to be used to refresh trained staff or train
new staff.
All phases of the training included multiple simula-
tions for a variety of shock and hemorrhage situations
(how to transport, placing on conscious and uncon-
scious women, removing when a woman is stable and
remains stable, replacing if a woman goes back into
shock, etc.). Simulations have been documented to im-
prove retention and team work [37, 38]. We also held
unexpected “emergency simulations” during lunch and
break times, when participants did not expect to be
performing a simulation. An actor playing the husband
would carry in an “unconscious and dying,” severely
shocked patient/actress and participants had to quickly
form a team and demonstrate how they would apply
the NASG, manage the hemorrhage and shock of the
unconscious and dying actress, and make a referral/
transport if necessary.
At the trainings facility staff were informed that they
would be receiving the CUG network phones, which be-
came property of the Regional Medical Office. Those
who accepted the CUG phones on behalf of the facility
signed a contract outlining obligations for maintenance
and use, as well as conditions in case of loss or damage.
During the Phase 2 training, an introduction to the elec-
tronic data collection forms was presented. CEmOC fa-
cilities were given onsite training for the electronic
forms when their CUG phones were distributed.
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Phones distributed for use with the CUG network were
Java-enabled Nokia phones. The closed user group was a
subscription service through the Airtel company, which
provided SIM cards for mobile phones to make calls at no
cost to other phones on the network. The CUG phones
were also programmed with a data entry system created
on OpenXdata. Data was transmitted from the phones via
General Packet Radio Service (GPRS) using an http proto-
col to send data to a local server running a MySQL data-
base for storage and management. The data could be
accessed remotely using a secure web-based platform lo-
cated at: http://maternal.esurveillance.or.tz/.
Entry Criteria/Enrollment: Women were included in
the study if they presented with or developed hypovol-
emic shock secondary to OH at any participating facility.
Staff were instructed to apply the NASG for women pre-
senting with signs of obstetric hemorrhage and hypovol-
emic shock, whether the patient would be referred out
or managed on site.
Hemorrhage Management: All facilities had received
training on EmOC through the Empower project.
Evidence-based guidelines for PPH management in-
cluded prophylaxis with uterotonics, treatment for PPH
with uterotonics, Intravenous fluids, and referral/trans-
port of women who continued to bleed despite utero-
tonic treatment.
Outcome Indicators: As this was an implementation
project, the main outcomes were increased and appro-
priate use of NASG and CUG network. We set project
targets for improvement at 75% increase from the base-
line of 0, since both technologies had never been used
before. Process indicators included: percentage of facil-
ities with an NASG available and locatable in < 10 min,
percentage of health facilities in compliance with estab-
lished NASG disinfection protocols, percentage of facil-
ities with a CUG network phone available, percentage of
facilities able to show a charged CUG network, percent-
age of facilities that conducted regular training drills,
and percentage of phones lost. We also compared base-
line case fatality rates (CFR) from OH with endline CFR
and predicted a decrease of 25%.
Data collection
From July –August 2014, IHI staff traveled to each of
the 280 sites to collect baseline data. This consisted of
reviewing all available hard copy registries to determine
the CFR, looking at cases of reported OH and number
of deaths attributed to OH for the 12 months from July
1, 2013 – June 30, 2014, the facility-based numbers were
compared to the official Regional Reports. Baseline data
were also gathered on availability of electricity, presence
of cell phones for referrals, and transportation availabil-
ity for all sites. The number of annual deliveries was
gathered from district reporting.
Paper-based data collection on NASG use at the CEmOC
facilities occurred from Dec 2014-March 2015, however as
not all sites had begun NASG implementation, this data
was used for training purposes only and not included in the
analysis. CUG network phones were rolled out to all facil-
ities during March–April 2015 during the Phase 2 BEmOC
trainings. Both paper forms and electronic data entry forms
were written in Swahili.
Facility staff were instructed to complete a case report
for each woman with signs of obstetric hemorrhage. This
data was recorded on a hard copy register for each site,
and later entered into the electronic OpenXdata data
entry form on the CUG phone and submitted to the
central server by designated health care providers who
had been trained for each facility. When there were
discrepancies in the electronic records, data was verified
against the paper-based register, and if additional verifica-
tion was required, against other maternity and gynecology
registries. In addition, sites sent month-end reports sum-
marizing the number of deliveries, the number of obstetric
hemorrhages, and the number of maternal deaths. This
data was used to ensure 1) that all facilities were sending
data on a regular basis 2) that the total number of OH re-
ported was equal to the number of detailed OH case re-
ports received. In cases of discrepancies or when the
month-end report had not been submitted, the project
team called facility staff using the CUG network to request
the reports.
In addition to the patient data, the data form con-
tained a free text comment field which allowed the pro-
vider to supply any additional information. Other fields
allowed providers to give the reason they did not use
uterotonics, the NASG, or the CUG phone for each pa-
tient if applicable.
Besides the quantitative electronic data on patient out-
comes, we used a supervision tool to record the process
indicators described above to ensure that the NASGs
and CUG phones were at the facility and in working
condition. These forms were completed by project staff
during three rounds of supervision, with all 280 sites vis-
ited during each of the three rounds. The final forms
were completed during the April–May 2016 supervision
as an endline measure.
On-site supervision was conducted three times through-
out the 15 months: from July – August 2015, December
2015 – January 2016, April – May 2016. Each site re-
ceived three visits by project staff, at which time they
were asked to demonstrate their skills, electronic re-
ports were verified against paper records, and trouble-
shooting was performed for the phones. The physical
condition of the NASGs and phones were verified and
recorded on the supervision forms along with the
number of staff trained, the number of staff not yet
trained, and the frequency of drills.
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Qualitative data collection
Feedback was sought to further enhance training and
use of CUG and NASG. In addition to the patient data,
the data forms contained the free text comment field
noted above, which allowed the provider to supply any
additional information. Qualitative informal interviews
were conducted with facility staff during all three rounds
of routine supervisory visits for sites, focusing on sites
with apparent overuse (use on women not meeting cri-
teria) or with lower numbers of uses than predicted.
For 2 weeks in July 2015, formal interviews were con-
ducted with 19 facility staff, 15 of them working at the
dispensary level, about their experiences with NASG.
Thirteen of the staff had been trained, but not yet had a
patient that required application of the NASG. Ques-
tions focused on ease of use, reasons for overuse or
non-use, suggestions for improving training, and NASG
acceptability. Due to the timing during the earlier stage
of the project, most of the interviews focused on pro-
viders’ confidence and theoretical concerns following
their training, as few providers had prior experience.
Data analysis Quantitative data analysis was con-
ducted using R (R Core Team (2017). R: A language
and environment for statistical computing. R Founda-
tion for Statistical Computing, Vienna, Austria. URL
https://www.R-project.org/) and Stata 12.1 (StataCorp.
2011. Stata Statistical Software: Release 12. College
Station, TX: StataCorp LP). Cohort study Risk Ratio
(RR) methods within Stata were used to compute rela-
tive risk and Chi-Square statistics for the association
of the use of the NASG with case fatality rates. Quali-
tative data analysis was conducted by seeking themes
within the various responses to open-ended fields and
to the structured one to one interviews.
Results
One thousand seven-hundred thirteen women with
obstetric hemorrhage from any etiology were observed
during the 15-month data collection period, with report-
ing from 276 facilities (98.6%). Estimated median blood
loss was 500 mL (n = 1672, 97.6%), range 0 ml–3500 ml).
Only 5.4% (n = 92) of women were missing blood pressure
recordings and 5.6% (n = 96) were missing pulse, but
consciousness level was recorded for all women. Blood
loss estimates were missing for 3.0% (n = 51) of women.
Additionally, 1.4% of facilities (4 dispensaries) failed to
send any reports (monthly totals or individual cases).
Table 1 compares conditions between women who had
OH (n = 1713), but did not receive the NASG (n = 1256),
and those women who had OH and did receive the NASG
(n = 457). The majority of the women who received the
NASG had lower SBPs and were more likely to have altered
level of consciousness. Of the 1713 women with OH, 419
(24.5%) met project hypovolemic shock criteria. Table 2
compares only those women who met study criteria of
hypovolemic shock secondary to OH (n = 419), and shows
worsening conditions and rates of use for different etiologies
among those who received the NASG (n = 297) and women
who did not receive the NASG (n = 122). As shown in Fig. 2,
the NASG was applied to 70.8% (n = 297) of these women.
Of the subgroup of 225 women (53.7%) experiencing shock
who were transported to higher level care, 85.8% (n = 193)
had the NASG applied before transfer, exceeding project tar-
gets of 75%. Of these 225 women transferred, 164 (72.8%)
had referral communication using the CUG network.
A comparison of CFR at baseline (1.70) to CFR at the end
of the project (0.76) showed a 67% reduced risk for women
during the project ([RR: 0.33, 95% CI = .19, .60], not shown).
Supplemental qualitative data was voluntarily added by
providers for 66.4% (n = 1138) of the hemorrhage cases
in the free text comment field of the data screen: This
field was frequently used to send positive feedback re-
garding the program such as:
“NASG helped, patient came to normal 120/60.” (Was
70/40).
“NASG has helped the patient keep well”.
“Died and back, NASG saves lives.”
Nasg inaokoa maisha ya akina mama “NASG saves
mother’s lives.”
Mgonjwa alishukuru sana watoa huduma vazi lilimuo-
koa “The patient thanked the service providers who had
saved her”.
Challenges were also reported, mainly when ambu-
lances or other transport were called, but did not arrive
for referrals, resolving missing data on hard copy records
with electronic records, and additional support requests
for training or referrals.
Interview data theme analysis showed the following cat-
egories of obstacles and opportunities in the early days of
the implementation project: perceived training needs,
Table 1 Characteristics of all women with Obstetric Hemorrhage
(n = 1713), those who received the Non-pneumatic Anti-Shock
Garment (n = 297), and those who did not receive the










≤ 80 183 (73.2) 67 (26.8) 250 (100)
81–90 113 (47.7) 124 (52.3) 237 (100)
> 90 147 (13.0) 987 (87.0) 1134 (100)
Missing 14 (15.2) 78 (84.8) 92 (100)
Consciousness level
Normal 230 (16.4) 1176 (83.6) 1406 (100)
Confused/
unconscious
227 (73.9) 80 (26.1) 307 (100)
Mbaruku et al. Reproductive Health          (2018) 15:177 Page 6 of 11
limitations to cascade training, desire for experience, and
transportation difficulties [39]. From these early interviews,
we learned how to improve the training and implementa-
tion of the project. Due to low patient volume at the dis-
pensaries, these providers expressed fears that they
anticipated not being proficient enough to apply the NASG
correctly. There was a belief expressed that perhaps practice
should occur on live patients in a hospital environment, ra-
ther than in a controlled simulation of the training center.
Process indicators
Data collected during endline supervision are reported in
Table 3. At endline, 280 facilities (100%) had an NASG
and 271 (96.8%) had all their NASGs disinfected, laun-
dered, folded, and stored in an area where they were not
exposed to potential damage by pests. The only indicator
where facilities did not exceed targeted outcomes, was
that only 43% reported conducting regular training drills.
Discussion
This large scale implementation project in rural Tanzania
demonstrated that appropriate utilization rates of 71% of
women in hypovolemic shock could be achieved, even in
lower level health care facilities. Positive contributing fac-
tors included adequate, frequent training and supportive
supervision to use the NASG, clear definitions and param-
eters of hypovolemic shock, rapid and responsible access
from project management and clinicians via the CUG, and
intensive follow up for every death that occurred and for
cases of non-use with women who met eligibility criteria.
Although there was some use on women who did not
meet the hypovolemic shock criteria, none of these
women suffered side effects or morbidities/mortalities.
The study also showed a temporal association of a 67% de-
crease in CFR in the study facilities at the project endline.
Alongside the near universal use of NASG for critically ill
women with obstetric hemorrhage reported from one
high-level facility in Cali, Colombia [27], this project dem-
onstrated high utility among providers in very different set-
tings and among different types of providers in rural
Tanzania. Likewise, in Tamil Nadu State in India, the
NASG has almost universal application at all levels of
health care facilities, including on all 108 Emergency Man-
agement and Research Institute ambulances throughout
the state [40]. In Timor Leste among ambulances and lower
level facilities, there was uptake of NASG, including use on
40/86 PPH cases in only a 10-month period. The Colombia,
Tamil Nadu, Timor Leste results, and this report contradict
a finding of low utilisation from an evaluation of a national
implementation project in Niger, in which misoprostol,
UBT, and NASG were introduced. Of the 59 maternal
deaths reviewed, only 4 women received the NASG [33].
However, the protocol for that project instructed that the
NASG should not be applied for every woman with PPH.
Rather, a sequenced approach was used, patients were given
prophylactic misoprostol, then, if a hemorrhage occurred,
the woman was treated with misoprostol. If the woman con-
tinued bleeding, a UBT was inserted. If the above treatments
did not stop the bleeding, then NASG would be applied
[26]. The low percentage of uses reported might indicate that
the first two steps (miso and UBT) avoided some of the need
for the NASG. However, limitations around primary data
collection make it difficult to determine. In conversation
with a national trainer from Health and Development Inter-
national (HDI), the implementing organization working with
the MOH in Niger (Zeidou A 2018, oral communication 14
August 2018), we learned that the Niger project did not keep
Table 2 Characteristics of women who met study criteria of
hypovolemic shock secondary to obstetric hemorrhage (n = 419)
who received non-pneumatic anti-shock garment (n = 297) and
women with hypovolemic shock who met criteria, but did not










Referred to higher care
Yes 193 (85.8) 32 (14.2) 225 (100)
No, managed at
facility
104 (53.6) 90 (46.4) 194 (100)
NASG applied
Yes 297 (100) 0 (0) 297 (71)




46 (41.8) 64 (58.2) 110 (100)
Uterine atony 65 (84.4) 12 (15.6) 77 (100)
Retained placenta 50 (79.4) 13 (20.6) 63 (100)
Placenta previa 33 (78.6) 9 (21.4) 42 (100)
Placental
abruption
30 (85.7) 5 (14.3) 35 (100)
Ruptured uterus 25 (73.5) 9 (26.5) 34 (100)
Lacerations 23 (88.5) 3 (11.5) 26 (100)
Ectopic pregnancy 4 (66.7) 2 (33.3) 6 (100)
DIC 5 (83.3) 1 (16.7) 6 (100)
Other 16 (80.0) 4 (20.0) 20 (100)
Systolic blood pressure
≤ 80 183 (73.2) 67 (26.8) 250 (100)
81–90 52 (76.5) 16 (23.5) 68 (100)
> 90 56 (59.6) 38 (40.4) 94 (100)
Missing 6 (85.7) 1 (14.3) 7 (100)
Consciousness status
Normal 70 (62.5) 42 (37.5) 112 (100)
Confused 148 (75.5) 48 (24.5) 196 (100)
Unconscious 79 (71.2) 32 (28.8) 111 (100)
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its own data throughout the project; they attempted to do so
in 2015, but following low (approximately 5%) reporting they
were asked by government partners to halt and transition to
the use of official government regional reporting. Beginning
in 2016 they only utilized MOH reporting. For these reasons,
the evaluation team conducted its own data collection, by
reviewing the case records on only 59 (35%) of the 171 re-
ported deaths. Finding a use of NASG on only 7% of the
women included in the mortality review, may not reflect low
use of NASG. It might, instead, be more interesting to see
the numbers/percentages of use on women with severe
hemorrhage/hypovolemic shock who did not die. Since that
data is not available, it seems improbable that this low rate
of NASG can be generalizable to the other women in this
project or to any other project. While we agree that hypovol-
emic shock secondary to OH is a rare event, it is still pos-
sible to demonstrate adequate use with more reliable data.
It is also possible that differentials between other reports
and the Niger report could be due to different approaches
to training in the Empower project (frequent doses, higher
use of simulations and practice), supportive supervision,
close follow-up of cases, or use of primary concurrently
collected data as seen in Tanzania and Timor Leste. Lower
utilization rates, < 35% of PPH cases, found in two Niger-
ian states, Ibadan [30] and Ondo [28], may also reflect
these differences in training, supply chain, exchange and
return plans, political support, policy support, regulations
over who can use NASGs (not allowing midwives, the
front line workers, to use NASGs) [30]. They might also
reflect examining rates of use against all OH cases, rather
than only the severe cases with hypovolemic shock.
However, even the projects reporting lower than ex-
pected use can impart important lessons about project
implementation of new technologies. We note in our
study and in others a preference for onsite training with
real OH cases, more hands-on skills sessions, and that
the rarity of severe PPH may result in loss of skills’ com-
petencies. We noted this in our first round of qualitative
interviews [39]. The Tanzania project seemed to have re-
duced some of these problems, first in the initial plan-
ning and then through course corrections responding to
feedback; instituting a phased approach with adequate
Fig. 2 Use of NASG for Women with Hypovolemic Shock Secondary to Obstetic Hemorrhage from April 1, 2015-June 30, 2016
Table 3 Endline supervision of facility process indicators N = 280 FACILITIES
Indicator Baseline Endline Target






























Mbaruku et al. Reproductive Health          (2018) 15:177 Page 8 of 11
time during training for hands-on skills practice and
team work; time to learn lessons and make course cor-
rections before widespread implementation; continuous
real-time review of hemorrhage case reports to determine
whether the NASG was being used appropriately on
women with hypovolemic shock, with follow-up conducted
by CUG for facilities/individual staff that had problems
with compliance in use of the NASG or reporting data;
ability to contact project staff over the CUG system when
challenges or questions arose; ability of district staff who
were certified during the TOT to provide supervision and
retraining during their routine quarterly site visits; encour-
agement of skills practicum sessions at the facility level to
overcome rarity of severe PPH cases; and the ability for fa-
cility staff to view training videos on the CUG phones.
In Tanzania the utilization by already trained providers
of a new emergency obstetric first-aid device for severe
hemorrhage cases, which often cause high anxiety and fear,
involves a difficult behavior change [41–43]. The Empower
providers have been dealing with severe hemorrhage and
maternal mortality, often for years, and often with horrible
outcomes. Intensive hands-on simulation training during
the project may have helped overcome this obstacle. Hav-
ing the videos on their phones may have also decreased
anxiety as newly trained health care workers had a readily
available model to show application and management.
These providers were already highly motivated by partici-
pation in Empower I and II, already updated on PPH man-
agement, EMOC, and improving referrals.
In some reports which recommend more hands-on
training, they also suggest that the training might be
costly. In this project, except for the two original TOTs,
training for NASG/CUG was incorporated into ongoing
EmOC training. Another question about costs, involve the
CUG system and its sustainability. While we did not do a
formal cost analysis, Regional Tanzanian government offi-
cials managing health services already had a budget equal
to $175 USD per month to cover communications costs
for four officials in a single region. This is equal to the
monthly cost for the entire CUG network which covered
all the health facilities in one district, as well as the District
Medical Officers, who also received phones as part of the
project. There are also comments about the “high costs”
of the NASG. For this project, the initial purchase price
was $55.00/per NASG. As the NASG can be washed and
re-used multiple times, this results in a highly
cost-effective management tool [19, 44, 45].
Limitations
While not a limitation to an implementation project, limita-
tions to this project’s generalizability should be noted. This
was not a randomized clinical trial, we compared endline
process indicators results to baseline rates of 0 at baseline
where there were no NASGs or CUGs available. We did
encounter some difficulties with data collection on paper
forms and with referrals on the providers’ own cell phones,
this resulted in the switch to the CUG phone network and
electronic data collection. The temporal differences since
baseline, such as participation in Empower trainings could
also have improved the providers’ EmOC skills; there may
have been an increase in the number of women who re-
ceived appropriate prophylaxis and/or treatment utero-
tonics during the intervention period as compared to the
baseline period. Included in limitations were limitations to
the training, particularly during the first few months, how-
ever, we did collect qualitative data on obstacles, and were
able to respond and make course corrections in the training
to emphasize even more simulations, practicums, and
hands-on experiences. Total reporting was from 98.6% of
all facilities, with all non-reporting facilities being dispens-
aries. Reports were received from all referral sites. The facil-
ities that were unable to send reports had low network
coverage or other technical obstacles, including being too
close to the Zambian border to connect to a Tanzanian net-
work. We attempted to overcome these difficulties by re-
trieving hard copy forms, sending a local project technician
to troubleshoot the phones, or by having facility staff travel
to an area with service in order to send monthly reports;
however 4 facilities did not succeed in sending reports and
were excluded from analysis. The emphasis was placed on
ensuring all the referral facilities had complete reporting.
There are methodological limitations with comparing CFR
at baseline to CFR at endline, including the fact that other
factors besides the NASG that could have affected the CFR
outcomes during the project period. We will conduct fur-
ther analyses on this data to investigate this association.
Strengths
However, there are many strengths to this project. First
this was a real-world implementation project in rural fa-
cilities with a high need for overcoming delays in dis-
tance and in lack of definitive shock treatment at lower
levels. There were high numbers of facilities (280) across
a number of levels of a health care system. There were
high response rates among facilities participating in the
project, in the trainings, and in reporting. Embedding
the NASG/CUG components into overall EmOC train-
ing was a strength, and also improved cost-effectiveness
vs. holding a separate, stand-alone training. Management
referrals and follow up with the CUG was a big strength,
which contributed not only to the high response rates
and validation of statistics, but also to case referral fol-
low up. Evidence-based training in management of OH
in the Empower II Project, followed, in our trainings,
with clear objective clinical parameters of hypovolemic
shock secondary to OH (not just an unreliable blood loss
estimation), enabled the providers to appropriately apply
NASGs to those women who really needed them.
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Another method of ascertaining accuracy in utilization
was the careful follow-up of mortalities and non-use
through continuous review of incoming OH reports and
month-end reporting accompanied with follow-up by
CUG phone if reports were not received, if the facilities
reported fewer than anticipated OH cases, or if case
management appeared inconsistent with protocols for
appropriate NASG use. If phone calls did not work to
improve both reporting or use, the issue was escalated
to facility management and ultimately district level man-
agement for in-person follow-up by a senior trainer.
While these are not necessary in all implementation
studies, this rigor did allow the project to demonstrate
that high utilization is possible. At the end of the pro-
ject, the region of Singida had generated sufficient gov-
ernment support to enable the region to independently
scale up to the three districts that had not been included
in the project, using their regional trainers and purchas-
ing the necessary NASGs. For sustainability, the inten-
sive follow up and data collection could be eliminated,
but the simulation training and emphasis on supportive
supervision could be more affordably sustained.
Conclusion
Despite few existing reports on real world use of the
NASG within rural health care settings, this study of
276 reporting facilities and over 1000 providers sup-
ported via CUG demonstrated that NASG can have
high uptake with appropriate use for hypovolemic
shock secondary to OH. A phased introduction, practical
hands-on training, supportive supervision as needed
through the CUG network, real-time monitoring of OH
case reports, and ability to watch training videos on the
phones seem to be keys to acceptability and utilization. In-
corporating NASG/CUG training into already established
EmOC training and implementations also enhanced pro-
gram success. It is clear by comparison to projects with
fewer or lower quality and/or stand-alone training, super-
vision, communication, and referrals that a one-time
training followed by distribution of the NASG to clinics
and facilities might result in low utilization. Adding NASG
training to pre-service curricula may further enhance up-
take for new nurses, midwives, doctors, and other skilled
maternal health care workers, who will arrive at their new
posts already possessing skills and confidence in NASG
application, management, and removal. With the proper
implementation strategies, NASG utilization can be high
and should be associated with decreased mortality among
mothers at risk of death from obstetric hemorrhage.
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